logo
OF SPECIAL INTEREST
FDA approves thrombopoiesis-stimulating agent
New drugs and dosage forms
Communication experts call on FDA to improve message delivery
Pharmacists matter in pandemic response
When pharmacy managed drug administration
Book Correction Notice
Pharmacist interventions in an inpatient geriatric psychiatry unit
HIV postexposure prophylaxis availability in U.S. rural hospitals
Need for residency programs in health-system pharmacy administration in the VA health care system
Certification of pharmacy technicians
A new term for transcribing
Why ASHP publishes Best Practices
Ranibizumab for neovascular age-related macular degeneration
Unlabeled uses of intravenous immune globulin
Evaluating the association between clozapine and venous thromboembolism
Intraurethral fluorouracil and lidocaine for intraurethral condyloma acuminata
Prevention of intravenous drug incompatibilities in an intensive care unit
Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement
Rosiglitazone and pioglitazone in the treatment of diabetes mellitus
Disclosure and ethical conduct of clinical research
Intervention design, implementation, and evaluation